Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
CaligorRx.com Global Access Programs Bridging the GAP Addressing unmet medical needs of patients “With the advent of social media platforms, global demand for access to medicines is at an all-time high. Pharmaceutical and Bridging the GAP biotechnology companies must be prepared to respond to physicians and patients. In an effort to foster an ethical response, positive publicity and ensure regulatory compliance, companies may inquire as to what approach they should take for these programs. Caligor provides the answers to these questions by effectively filling the access gap.” MEDICATIONS WITH LIMITED ACCESSIBILITY PATIENTS NEEDING MEDICATIONS I N T E R NAT I O N A L R E G U L AT I O N S Providing physicians with access to medicines unavailable in their countries has revolutionized the way in which pharmaceutical and biotech companies serve patients in need. These programs, called Global Access Programs (GAP), can be complex given the dynamic regulatory environment, the unpredictability of requests and the speed at which these medicines need to be delivered to patients. Caligor bridges the gap between medicines with limited availability and patients in need using our innovative regulatory-compliant programs for drug access. Working alongside your team, we provide strategies to facilitate optimal access throughout the product life cycle including the delivery of drug to sites into over 100 countries. Caligor GAPs can be implemented during various points in the lifecycle, such as: • Still in clinical development but having sufficient safety / efficacy data •A s an optimal solution for patients exiting trials and / or in lieu of open label extension studies while commercializing worldwide • Where the medicine is licensed in one or more countries, but not in the patient’s country Caligor GAPs are unique in that they are established on the basis of a clinical trial model but adapted and customized to reflect the specific needs of an access program. Our approach uses validated clinical trial e-tools and platforms that sponsors, physicians and sites have come to expect. Our “full-service” approach allows companies to remain focused on the drug development process while we manage all aspects of the program. CaligorRx.com Global Access Programs “Our team understands the critical For sponsors, the benefits of Global Access Programs are: importance of strong and effective • Controlled access and strong visibility of demand patterns relationships with sponsors and • First look at “real-world” data sites, thus we only employ sea- • Fostering of early relationships with physicians, patients and regulators soned program operations team • Increased product awareness / experience prior to launch members with direct clinical trial • Potential for revenue stream experience.” Caligor is uniquely qualified as your Global Access Program partner based on our four pillars that support program success. TEAM TECHNOLOGY LEADERSHIP FULL-SE RVICE BE ST-IN-IN DUSTRY LEADERSHIP Program Success SEASONE D PROGRAM MANAGEME NT UN IQUE IN NOVATIVE FULL-SE RVICE TECHNOLOGY TEAM PARTNE R Our leadership consists of key individuals with many years of experience in this niche space and who can strategically unlock the value of your access program. The full service approach allows companies to “hand off” these critical programs to an expert so they can remain focused on the clinical development and commercialization efforts. Caligor has implemented the latest e-tools and platforms that sponsors and physicians recognize, allowing for ease of use and 24/7/365 accessibility. In addition, we only employ experienced program team members that have clinical trial experience and understand the nuances of working with global sites, sponsors and their affiliates. Our programs also give visibility to real time access to your real world data. Another key to our success in delivering high value GAP medicines to sites around the world is our state of the art facilities in both the US and the UK, enhanced by our worldwide strategic warehouse depots. We partner with a range of speciality couriers to ensure there is a high touch element to transporting your medicines to physicians and patients in need guaranteeing that there are no delays in delivery. Caligor Rx Inc. Caligor Rx Ltd. 801 Penhorn Avenue No.4 Secaucus, NJ 07094 USA Unit 23 Schooner Park Schooner Court Crossways Business Park Dartford Kent DA2 6NW United Kingdom +1 212.988.0590 +44 (0) 1322 311 134 Planning for and establishing an access strategy with Caligor early in the product development cycle offers companies the ability to understand demand and have the optimal provision and company position for granting access throughout the lifecycle. By entrusting Caligor to manage your Global Access Program, you can be assured that your program is being managed by a highly experienced team that considers themselves an extension of your organization. For more information about our Global Access Programs, please contact us at: [email protected]